Patents by Inventor Francois-Xavier Orveillon

Francois-Xavier Orveillon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of producing an immunogenic composition
    Patent number: 11957746
    Abstract: The present invention in particular relates to a method of producing an immunogenic composition exhibiting reduced virucidal activity, as well as to the immunogenic composition and uses thereof, wherein the method in particular comprises the steps of: (a) providing a mixture with a first liquid and a recombinant protein, (b) concentrating the recombinant protein in the mixture by removing a portion of the first liquid from the mixture, and (c) processing the solution resulting from step (b) by continuous diafiltration.
    Type: Grant
    Filed: March 25, 2019
    Date of Patent: April 16, 2024
    Inventors: Leigh Wilmes, Matthew Coons, Amanda Brown, Michael Johannes Gassel, Francois-Xavier Orveillon, Katharina Hedwig Toepfer, Elida Bautista, Kathy Schlesinger
  • METHOD OF PRODUCING AN IMMUNOGENIC COMPOSITION
    Publication number: 20220409715
    Abstract: The present invention in particular relates to a method of producing an immunogenic composition exhibiting reduced virucidal activity, as well as to the immunogenic composition and uses thereof, wherein the method in particular comprises the steps of: (a) providing a mixture with a first liquid and a recombinant protein, (b) concentrating the recombinant protein in the mixture by removing a portion of the first liquid from the mixture, and (c) processing the solution resulting from step (b) by continuous diafiltration.
    Type: Application
    Filed: March 25, 2019
    Publication date: December 29, 2022
    Inventors: Leigh WILMES, Matthew COONS, Amanda BROWN, Michael Johannes GASSEL, Francois-Xavier ORVEILLON, Katharina Hedwig TOEPFER, Elida BAUTISTA, Kathy SCHLESINGER
  • Treatment of pigs with PCV2 antigen
    Patent number: 10780156
    Abstract: The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.
    Type: Grant
    Filed: May 15, 2018
    Date of Patent: September 22, 2020
    Inventors: Vicky Fachinger, Knut Elbers, Axel Lischewski, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Freiin Von Richthofen, Michael D. Piontkowski
  • European PRRSV strain
    Patent number: 10668144
    Abstract: The present invention is related to improved modified live PRRS vaccines containing new PRRSV European strains of PRRSV and methods of use and manufacture of such vaccines.
    Type: Grant
    Filed: June 28, 2018
    Date of Patent: June 2, 2020
    Inventors: Kim Burgard, Jeremy Kroll, Sarah M. Layton, Volker Ohlinger, Francois-Xavier Orveillon, Stefan Pesch, Michael Dennis Piontkowski, Michael B. Roof, Philip Utley, Eric Martin Vaughn
  • NOVEL EUROPEAN PRRSV STRAIN
    Publication number: 20190134180
    Abstract: The present invention is related to improved modified live PRRS vaccines containing new PRRSV European strains of PRRSV and methods of use and manufacture of such vaccines.
    Type: Application
    Filed: June 28, 2018
    Publication date: May 9, 2019
    Inventors: Kim BURGARD, Jeremy KROLL, Sarah M. LAYTON, Volker OHLINGER, Francois-Xavier ORVEILLON, Stefan PESCH, Michael Dennis PIONTKOWSKI, Michael B. ROOF, Philip UTLEY, Eric Martin VAUGHN
  • TREATMENT OF PIGS WITH PCV2 ANTIGEN
    Publication number: 20180250380
    Abstract: The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.
    Type: Application
    Filed: May 15, 2018
    Publication date: September 6, 2018
    Inventors: Vicky FACHINGER, Knut ELBERS, Axel LISCHEWSKI, Marion KIXMOELLER, Francois-Xavier ORVEILLON, Isabelle FREIIN VON RICHTHOFEN, Michael D. PIONTKOWSKI
  • European PRRSV strain
    Patent number: 10039821
    Abstract: The present invention is related to improved modified live PRRS vaccines containing new PRRSV European strains of PRRSV and methods of use and manufacture of such vaccines.
    Type: Grant
    Filed: November 22, 2016
    Date of Patent: August 7, 2018
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Kim Burgard, Jeremy Kroll, Sarah M. Layton, Volker Ohlinger, Francois-Xavier Orveillon, Stefan Pesch, Michael Dennis Piontkowski, Michael B. Roof, Philip Utley, Eric Martin Vaughn
  • Treatment of PRDC in pigs
    Patent number: 10010604
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.
    Type: Grant
    Filed: November 9, 2016
    Date of Patent: July 3, 2018
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Freiin Von Richthofen, Axel Lischewski
  • Treatment of pigs with PCV2 antigen
    Patent number: 10010603
    Abstract: The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: July 3, 2018
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Axel Lischewski, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Freiin Von Richthofen, Michael D. Piontkowski
  • Prevention and treatment of sub-clinical PCVD
    Patent number: 9943587
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Grant
    Filed: December 13, 2016
    Date of Patent: April 17, 2018
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois Xavier Orveillon, Isabelle Freiin von Richthofen, Axel Lischewski
  • PREVENTION AND TREATMENT OF SUB-CLINICAL PCVD
    Publication number: 20170087241
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Application
    Filed: December 13, 2016
    Publication date: March 30, 2017
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois Xavier Orveillon, Isabelle Freiin von Richthofen, Axel Lischewski
  • NOVEL EUROPEAN PRRSV STRAIN
    Publication number: 20170065709
    Abstract: The present invention is related to improved modified live PRRS vaccines containing new PRRSV European strains of PRRSV and methods of use and manufacture of such vaccines.
    Type: Application
    Filed: November 22, 2016
    Publication date: March 9, 2017
    Inventors: Kim BURGARD, Jeremy KROLL, Sarah M. LAYTON, Volker OHLINGER, Francois-Xavier ORVEILLON, Stefan PESCH, Michael Dennis PIONTKOWSKI, Michael B. ROOF, Philip UTLEY, Eric Martin VAUGHN
  • TREATMENT OF PIGS WITH PCV2 ANTIGEN
    Publication number: 20170049876
    Abstract: The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.
    Type: Application
    Filed: November 4, 2016
    Publication date: February 23, 2017
    Inventors: Vicky Fachinger, Knut Elbers, Axel Lischewski, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Freiin Von Richthofen, Michael D. Piontkowski
  • TREATMENT OF PRDC IN PIGS
    Publication number: 20170049878
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.
    Type: Application
    Filed: November 9, 2016
    Publication date: February 23, 2017
    Inventors: Vicky FACHINGER, Knut ELBERS, Marion KIXMOELLER, Francois-Xavier ORVEILLON, Isabelle FREIIN VON RICHTHOFEN, Axel LISCHEWSKI
  • Prevention and treatment of sub-clinical PCVD
    Patent number: 9555092
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Grant
    Filed: August 6, 2015
    Date of Patent: January 31, 2017
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois Xavier Orveillon, Isabelle Freiin von Richthofen, Axel Lischewski
  • European PRRSV strain
    Patent number: 9534207
    Abstract: The present invention is related to improved modified live PRRS vaccines containing new PRRSV European strains of PRRSV and methods of use and manufacture of such vaccines.
    Type: Grant
    Filed: May 19, 2014
    Date of Patent: January 3, 2017
    Assignee: Boehringer Ingelheim Vetmedica GmbH
    Inventors: Kim Burgard, Jeremy Kroll, Sarah M. Layton, Volker Ohlinger, Francois-Xavier Orveillon, Stefan Pesch, Michael Dennis Piontkowski, Michael B. Roof, Philip Utley, Eric Martin Vaughn
  • Prophylaxis and treatment of PRDC
    Patent number: 9522182
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.
    Type: Grant
    Filed: June 15, 2015
    Date of Patent: December 20, 2016
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Freiin Von Richthofen, Axel Lischewski
  • Treatment of pigs with PCV2 antigen
    Patent number: 9517260
    Abstract: The present invention relates to a method for the treatment or prophylaxis of a PCV2 infection or for reduction of clinical symptoms caused by or associated with a PCV2 infection in animals a) having anti-PCV2 antibodies and/or b) being young piglets of 1 to 22 days of age, comprising the step of administering an effective amount of a PCV2 antigen to that animal in need of such treatment. Preferably, those animals are pigs or young piglets.
    Type: Grant
    Filed: September 10, 2014
    Date of Patent: December 13, 2016
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Vicky Fachinger, Knut Elbers, Axel Lischewski, Marion Kixmoeller, Francois-Xavier Orveillon, Isabelle Freiin von Richthofen, Michael D. Piontkowski
  • PREVENTION AND TREATMENT OF SUB-CLINICAL PCVD
    Publication number: 20150343052
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment of sub-clinical PCV2 infection in animals, preferably in pigs.
    Type: Application
    Filed: August 6, 2015
    Publication date: December 3, 2015
    Inventors: Vicky Fachinger, Knut Elbers, Marion Kixmoeller, Francois Xavier Orveillon, Isabelle Freiin von Richthofen, Axel Lischewski
  • PROPHYLAXIS AND TREATMENT OF PRDC
    Publication number: 20150273046
    Abstract: The present invention relates to the use of an immunogenic composition comprising a porcine circovirus type 2 (PCV2) antigen for the prevention and treatment, including a reduction in the severity of, duration of, and manifestations of, porcine respiratory disease complex (PRDC) in animals, preferably in pigs.
    Type: Application
    Filed: June 15, 2015
    Publication date: October 1, 2015
    Inventors: Vicky FACHINGER, Knut ELBERS, Marion KIXMOELLER, Francois-Xavier ORVEILLON, Isabelle FREIIN VON RICHTHOFEN, Axel LISCHEWSKI